SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-326837
Filing Date
2018-11-14
Accepted
2018-11-14 17:18:53
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d623698d10q.htm 10-Q 582772
2 EX-10.30 d623698dex1030.htm EX-10.30 34617
3 EX-10.31 d623698dex1031.htm EX-10.31 58216
4 EXHIBIT 31.1 d623698dex311.htm EX-31.1 11162
5 EXHIBIT 31.2 d623698dex312.htm EX-31.2 11181
6 EXHIBIT 32.1 d623698dex321.htm EX-32.1 5745
13 GRAPHIC g623698g03m28.jpg GRAPHIC 120563
14 GRAPHIC g623698g1112235129781.jpg GRAPHIC 2998
15 GRAPHIC g623698img01.jpg GRAPHIC 14434
  Complete submission text file 0001193125-18-326837.txt   2974247

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT aldx-20180930.xml EX-101.INS 396721
8 XBRL TAXONOMY EXTENSION SCHEMA aldx-20180930.xsd EX-101.SCH 32740
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20180930_cal.xml EX-101.CAL 40447
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20180930_def.xml EX-101.DEF 114686
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20180930_lab.xml EX-101.LAB 274311
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20180930_pre.xml EX-101.PRE 190159
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 181185131
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1